Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q2

Carly Behm -  

Stryker, Johnson & Johnson and Zimmer Biomet all saw year-over-year total revenue increases during the second quarter, but their spine and orthopedic sales varied in growth.

Here is how their second-quarter performances compare:

Stryker

Total sales: $4.5 billion (+4.6 percent)

Orthopedics and spine: $1.9 billion (0.5 percent)

Hips: $364 million (+3.2 percent)

Knees: $500 million (+5.5 percent)

Johnson & Johnson

Total sales: $24 billion (+3 percent)

Spine, sports and other: $724 million (-6.8 percent)

Orthopedic: $2.2 billion (-3.1 percent)

Hips: $388 million (-0.7 percent)

Knees: $349 million (-0.1 percent)

Zimmer Biomet

Total sales: $1.8 billion (+1 percent)

Hips: $487.2 million (+2.7 percent)

Knees: $704.9 million (+5.9 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $446.4 million (-3.4 percent)

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers